NIFTY 50

Glenmark Pharma gets USFDA nod for Pimecrolimus Cream

Updated : August 30, 2019 09:46 AM IST

Mumbai-based Glenmark Pharma has received the US Food and Drug Administration's (USFDA) nod for Pimecrolimus Cream, which is used to treat atopic dermatitis.

The market size of Pimecrolimus Cream is around $200 million and it is expected to be a limited competition drug for Glenmark as there are only two players currently.

Glenmark is expected to make around $20-30 million from Pimecrolimus Cream.

The company, during its conference call, had said that it is going to receive around two opportunities in the US, one of which is this. Therefore, this should bode well for the company considering the pressure the stock has witnessed.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV